Gold colloid for immunochromatography
Gold colloid for diagnostic drug development and manufacturing - BBI Solutions, UK.
This is a gold colloid produced by BBI Solutions, widely used in the market.
BBI Solutions, a UK company, has over 20 years of experience in manufacturing gold nanoparticles for the research and diagnostic industry. The excellent stability, high sensitivity, and binding properties of the company's gold colloids will yield optimal results.
Inquire About This Product
basic information
【Main Lineup】 ■EMGC40 / Gold nanoparticles 40nm / 100mL ¥65,000 *Other particle sizes are also available (some conditions apply, such as order quantity) *Bulk supply for manufacturing is also accepted.
Price information
￥65,000（100ml）～
Price range
P2
Delivery Time
※The delivery date may vary depending on the quantity, so please feel free to contact us.
Applications/Examples of results
*Available only for research, development, and manufacturing purposes of in vitro diagnostic reagents.
Line up（1）
| Model number | overview |
|---|---|
| EMGC40 | Gold nanoparticles 40nm（100mL） |
catalog（2）
Download All Catalogs
Company information
Our company, BioDot Japan Co., Ltd., was established in February 2012 as the Japanese subsidiary of BioDot Inc. in the United States, and we have been supplying various diagnostic reagents and production equipment. BioDot Inc. is a venture company founded in 1994 in Irvine, California. The company’s self-developed non-contact micro-dispenser system (patented) has become the de facto standard for the development and production of immunochromatographic reagents and enzyme sensor reagents, widely used around the world. Additionally, the company has continuously commercialized peripheral devices, which have now become essential support equipment in these fields. However, we believe that in order to further advance the increasingly important clinical testing technologies, it is necessary to provide a wide range of raw materials, information, and services from both domestic and international sources, not just BioDot products. Therefore, we transformed into ForDix Co., Ltd. in December 2015. The technology for diagnostic reagents developed through clinical testing is also applied in food testing and environmental testing, supporting our lives beyond the medical field. As a company that supports those who research, develop, and commercialize these areas, we will strive to become a trusted presence.
